ATS 2018 International Conference

Seebri™ Neohaler® (Glycopyrrolate) Versus Placebo in Patients with Moderate to Severe COPD: Analysis of Health-Related Quality of Life (HRQoL) from the GEM2 Study [Board No. P1330]

Location: Board no. P1330

Session Type: Thematic Poster Session

Monday

May

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Krithika Rajagopalan

PhD
Sunovion Pharmaceuticals Inc.

Carole Dembek

MS
Sunovion Pharmaceuticals Inc.

Edward M. Kerwin

phd
Clinical Research Institute;Clinical Research Institute of Southern Oregon, PC;Crisor, LLC c/o Clinical Research Institute of Southern Oregon, Inc.

View Abstract

Seebri™ Neohaler® (Glycopyrrolate) Versus Placebo in Patients with Moderate to Severe COPD: Analysis of Health-Related Quality of Life (HRQoL) from the GEM2 Study

Parent Sessions

B33 - COPD: MAINTENANCE THERAPY
05-21-2018 9:15 AM - 4:15 PM

Event